Impact of COVID-19 on Patients Receiving Chemotherapy for Gynecological Cancer

    Mahmoud N. Andijani, Ahmad O Alibrahim, Sheren F. Tmraz … Khalid Sait
    Studysummary In this study, 9% of gynecological cancer patients undergoing chemotherapy at a Saudi Arabian hospital contracted COVID-19, and patients with recurrent disease showed higher COVID-19 incidence and mortality.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mejfm.com →
    Discuss this study in the Community →